A risk-benefit assessment of pharmacological treatments for panic disorder

Panic disorder, a psychiatric disorder characterised by frequent panic attacks, is the most common anxiety disorder, affecting 2 to 6% of the general population. No one line of treatment has been found to be superior, making a risk-benefit assessment of the treatments available useful for treating p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drug safety 1998-06, Vol.18 (6), p.419-430
Hauptverfasser:	Bennett, J A, Moioffer, M, Stanton, S P, Dwight, M, Keck, Jr, P E
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressive Agents, Tricyclic - adverse effects Antidepressive Agents, Tricyclic - therapeutic use Benzodiazepines - adverse effects Benzodiazepines - therapeutic use Humans Monoamine Oxidase Inhibitors - adverse effects Monoamine Oxidase Inhibitors - therapeutic use Panic Disorder - drug therapy Panic Disorder - therapy Psychotherapy Risk Assessment Serotonin Uptake Inhibitors - adverse effects Serotonin Uptake Inhibitors - therapeutic use Valproic Acid - adverse effects Valproic Acid - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!